Skip to main content

Noelia Rodríguez Villatoro

Institutions of which they are part

Research technician
Stroke research
Vall Hebron Institut de Recerca

Noelia Rodríguez Villatoro

Institutions of which they are part

Research technician
Stroke research
Vall Hebron Institut de Recerca

Projects

Influencia de factores clínicos, marcadores de neuroimagen y parámetros de laboratorio en el control de la presión arterial tras una hemorragia intracerebral aguda

IP: David Rodriguez Luna
Collaborators: Anna Bonaterra Pastra, Noelia Rodríguez Villatoro, Manuel Requena Ruiz, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 40000
Reference: PI23/01061
Duration: 01/01/2024 - 31/12/2026

PREDICTHOR: Predicción y mejora del resultado funcional en pacientes con ictus subagudo/crónico a través de telerehabilitación a domicilio basada en realidad virtual no invasiva

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Noelia Rodríguez Villatoro, Federica Rizzo
Funding agency: Instituto de Salud Carlos III
Funding: 158750
Reference: PI23/01680
Duration: 01/01/2024 - 31/12/2026

RES-Q PLUS: Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality

IP: Carlos Molina Cateriano
Collaborators: Noelia Rodríguez Villatoro, Juega Mariño, Jesus Maria, Federica Rizzo, David Rodriguez Luna, Carole Conforti, Renato Simonetti
Funding agency: EUROPEAN COMMISSION
Funding: 396730
Reference: RES-Q PLUS_HE-HLTH-TOOL21
Duration: 01/11/2022 - 31/10/2026

Empower-ICH: eficacia de la implementación de un sistema de telemonitorización de la presión arterial ambulatoria en pacientes con hemorragia intracerebral

IP: David Rodriguez Luna
Collaborators: Noelia Rodríguez Villatoro, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 38720
Reference: PI20/00834
Duration: 01/01/2021 - 30/06/2025

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Joan Piñas Massó

Joan Piñas Massó

Biomedical Research in Cancer Stem Cells
Read more
Gastelum Varela, Graciela

Gastelum Varela, Graciela

Predoctoral researcher
Diabetes and Metabolism
Read more
Francesc Casellas Jordá

Francesc Casellas Jordá

Physiology and Pathophysiology of the Digestive Tract
Read more
Garcia Arabehety, Julia

Garcia Arabehety, Julia

Research technician
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.